粒细胞生成
先天性中性粒细胞减少
中性粒细胞减少症
髓样
造血
骨髓
中性粒细胞弹性蛋白酶
粒细胞
川地34
免疫学
粒细胞集落刺激因子受体
内科学
粒细胞集落刺激因子
生物
医学
内分泌学
干细胞
炎症
化疗
细胞生物学
作者
Yasuyuki Sera,Hiroshi Kawaguchi,Kazuhiro Nakamura,Takashi Sato,Masakazu Habara,Satoshi Okada,Nobutsune Ishikawa,Seiji Kojima,Osamu Katoh,Masao Kobayashi
出处
期刊:PubMed
日期:2005-08-01
卷期号:90 (8): 1032-41
被引量:18
摘要
Cyclic neutropenia (CyN) in childhood and severe congenital neutropenia (SCN) are congenital disorders that cause chronic neutropenia. Mutations in the neutrophil elastase gene, ELA2, have been reported in patients with CyN and in those with SCN. We examined granulopoietic defects in CyN patients with those in SCN patients.Three patients with CyN and four with SCN were enrolled in this study. Bone marrow cells were enriched based on the expression of CD34, Kit, and granulocyte colony-stimulating factor receptor (G-CSFR). The purified cells were assayed for colony formation, proliferation, and mRNA expression of granular enzymes.All patients showed heterozygous mutations of ELA2. Flow cytometric analysis demonstrated no differences in the frequency of CD34, Kit, and G-CSFR expression between CyN patients and normal subjects. Significant differences in granulocyte/macrophage (GM)-colony formation of CD34(+)/Kit(+) cells were observed among CyN patients, SCN patients, and normal subjects in response to hematopoietic factors. Impaired granulopoiesis was found in both CD34(+)/Kit(+)/G-CSFR(+) and CD34(+)/Kit(+)/G-CSFR- cells in patients with CyN, whereas this impairment was observed only in CD34(+)/Kit(+)/G-CSFR(+) cells in SCN patients, as previously reported. The mRNA expression of granular enzymes in myeloid precursors and the transcription levels during myeloid cell differentiation in CyN patients were comparable to those in normal subjects, in contrast to the abnormal transcription of granular enzymes in SCN patients.These results suggest that the underlying granulopoietic abnormalities differ between CyN and SCN, and emphasize the presence of additional genetic pathophysiology specific to each disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI